Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Solid Biosciences Inc. Initial Public Offering
Davis Polk advised the joint book-running managers in connection with the $133.7 million initial public offering of common…
ConforMIS, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC…
Five Prime Therapeutics, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers in connection with a $115 million SEC-registered offering of 5,897…
Adamas Pharmaceuticals, Inc. Common Stock Follow-On Offering
Davis Polk advised the joint book-running managers in connection with a $124.5 million SEC-registered follow-on offering of…
Stemline Therapeutics, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the…
Agios Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the…
BeiGene, Ltd. $800 Million Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in the $800 million public…
Hologic, Inc. $1 Billion Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S reopening by…
Davis Polk Advises TiGenix on Its Acquisition by Takeda
Davis Polk is advising TiGenix in connection with its entry into an offer and support agreement with Takeda Pharmaceutical…
Denali Therapeutics Inc. Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 15,972,221 shares of common stock of…